PFE, MYL settle Lipitor and Caduet patent cases: http://finance.yahoo.com/news/Mylan-Announces-Lipitor-prnews-209565740.html?x=0&.v=1 http://finance.yahoo.com/news/Mylan-Announces-Caduet-prnews-2557401421.html?x=0&.v=1 No terms have been disclosed. The settlements are related insofar as Caduet is a combination pill of Lipitor + Norvasc. I think PFE may now have settled with all of the Paragraph-IV challengers to Lipitor and Caduet. If this is not true, someone please chime in.